Hint mode is switched on Switch off
For swift navigation between sections

Calliditas Therapeutics
LEI 549300PVPZO8TNT76B58

PDF download

Choose all Reset all
Download Cancel
Organization name
Calliditas Therapeutics AB
Country name
Sweden
Country of registration
Sweden
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Calliditas Therapeutics AB operates as a specialty pharmaceutical company in Sweden. The company is engaged in the provision of pharmaceutical products for patients with niche indications. It is focused on the development and commercialization of the product candidate Nefecon intended for the treatment of patients with the inflammatory renal disease IgA nephropathy, a disease that causes chronic inflammation of the kidneys.

Awards

News

03/09/2024 Calliditas Therapeutics to Apply for Nasdaq Delisting as Asahi Takeover Nears Completion
20/05/2024 Calliditas Therapeutics AB Earnings Preview and R&D Day Insights
All organization news

Documentation

IFRS/US GAAP reports

2023
IV q eng
2022
IV q eng
2021
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300PVPZO8TNT76B58
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001795579
  • Organisationsnummer
    556659-9766
Registration is required to get access.